智通财经APP获悉，港股恒生指数早盘跌1.38%，报22627点；恒生科技指数跌2.24%。港股早盘成交1695亿港元。
CRO概念股多数走高，行业有望进入稳增长阶段，AI制药技术等值得关注。昭衍新药(06127)涨17.83%；泰格医药(03347)涨13.49%；凯莱英(06821)涨6.74%；康龙化成(03759)涨4.88%。
腾盛博药-B(02137)逆市涨超25%，高盛指创新激励政策为中国生物科技企业创造更好的发展环境。
歌礼制药-B(01672)大涨26%，ASC30在肥胖症研究获得积极期中结果。
力劲科技(00558)再涨7.3%，广汽集团全面启动一体式压铸，机构看好压铸机需求反弹。
晶泰控股-P(02228)再涨超7%，联手恒健控股公司支持大湾区人工智能基础设施建设。
康耐特光学(02276)早盘涨4.3%，公司此前获歌尔股份入股，有望就智能眼镜相关业务加深合作。
东阳光长江药业(01558)涨超4%，将DeepSeek大模型全面接入HEC-Finder平台。
网龙(00777)早盘涨3.4%，Rokid Glasses有望二季度开售，公司23年战略投资Rokid。
固生堂(02273)再涨5.97%，近日宣布正式接入DeepSeek，深化中医个性化诊疗特点。
芯片股全线回落，华虹半导体(01347)跌4.7%，晶圆代工厂商或面临成熟制程价格压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.